Device helps kids in Michigan avoid anesthesia during cancer treatment
- The AVATAR device projects movies and TV shows above pediatric patients during radiation therapy.
- A study found that nearly 80% of children using the device could avoid anesthesia during treatment.
- This innovative approach aims to make cancer treatment less intimidating and more enjoyable for young patients.
At the University of Michigan Hospital, a new device called AVATAR is transforming the experience of pediatric patients undergoing radiation therapy. Developed at Stanford University, this innovative technology projects movies and TV shows directly above the patients' heads, helping to distract them during treatment. A recent study indicated that nearly 80% of children using the device were able to avoid anesthesia, which is often required for such procedures due to the need for patients to remain still. The implementation of AVATAR is part of a broader, team-based approach to pediatric cancer treatment. Radiation oncologist Michelle Kim emphasized the importance of making the treatment experience less intimidating for young patients. Child Life specialists play a crucial role in this process, engaging with children to enhance their comfort and understanding of the treatment. They utilize various strategies, including a motorized vehicle to transport patients to treatment rooms, ensuring that children are both entertained and calm. The positive impact of AVATAR is evident, as some children have expressed sadness when their treatment sessions conclude, indicating a lack of negative associations with the experience. For instance, a young patient who is a fan of Taylor Swift has been able to enjoy her treatments while watching the Era's tour, which has significantly helped her cope with the 45-minute sessions. Overall, the introduction of AVATAR at the University of Michigan Hospital represents a significant advancement in pediatric oncology, aiming to reduce anxiety and improve the overall treatment experience for children battling cancer.